Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial
钠-葡萄糖协同转运蛋白2抑制剂对COVID-19住院患者无器官支持生存期的影响（ACTIV-4a）：一项实用性、多中心、开放标签、随机、对照平台试验
期刊:Lancet Diabetes & Endocrinology
影响因子:41.8
doi:10.1016/S2213-8587(24)00218-3
Kosiborod, Mikhail N; Windsor, Sheryl L; Vardeny, Orly; Berger, Jeffrey S; Reynolds, Harmony R; Boumakis, Stavroula; Althouse, Andrew D; Solomon, Scott D; Bhatt, Ankeet S; Peikert, Alexander; Luther, James F; Leifer, Eric S; Kindzelski, Andrei L; Cushman, Mary; Ng Gong, Michelle; Kornblith, Lucy Z; Khatri, Pooja; Kim, Keri S; Baumann Kreuziger, Lisa; Javaheri, Ali; Carpio, Carlos; Wahid, Lana; Lopez-Sendon Moreno, Jose; Alonso, Alvaro; Ho, Minh Quang; Lopez-Sendon, Jose; Lopes, Renato D; Curtis, Jeffrey L; Kirwan, Bridget-Anne; Geraci, Mark W; Neal, Matthew D; Hochman, Judith S
